Obesity and HER 2 overexpression: A common factor for poor prognosis of breast cancer

International Seminars in Surgical Oncology

Volumn 5, Issue , 2008, Pages

  Sellahewa, Chaminda ^a   Nightingale, Peter ^b   Carmichael, Amtul R ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BODY MASS; BREAST CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS;

EID: 40749133332     PISSN: None     EISSN: 14777800     Source Type: Journal    
DOI: 10.1186/1477-7800-5-2     Document Type: Article

References (16)

1. Senie RT Rosen PP Rhodes P Lesser ML Kinne DW; Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-Free Survival. Ann Intern Med 1992, 116(1):26-32. 1727092
2. Petrelli JM Calle EE Rodriguez C Thun MJ: Body Mass Index, Height, and Postmenopausal Breast Cancer Mortality in a Prospective Cohort of US Women. Cancer Causes Control 2002, 13(4):325-32. 10.1023/A:1015288615472 12074502
3. Berclaz G Li S Price KN Coates AS Castiglione-Gertsch M Rudenstam CM Holmberg SB Lindtner J Erien D Collins J Snyder R Thurlimann B Fey MF Mendiola C Werner ID Simoncini E Crivellari D Gelber RD Goldhirsch A: Body Mass Index As a Prognostic Feature in Operable Breast Cancer: The International Breast Cancer Study Group Experience. Ann Oncol 2004, 15(6):875-84. 10.1093/annonc/mdh222 15151943
4. Galanis DJ Kolonel LN Lee J Le Marchand L: Anthropometric Predictors of Breast Cancer Incidence and Survival in a Multi-Ethnic Cohort of Female Residents of Hawaii, United States. Cancer Causes Control 1998, 9(2):217-24. 10.1023/A:1008842613331 9578299
5. Jain M Miller AB: Pre-Morbid Body Size and the Prognosis of Women With Breast Cancer. Int J Cancer 1994, 59(3):363-8. 10.1002/ijc.2910590312 7927942
6. Kroenke CH Chen WY Rosner B Holmes MD: Weight, Weight Gain, and Survival After Breast Cancer Diagnosis. J Clin Oncol 2005, 23(7):1370-8. 10.1200/ JCO.2005.01.079 15684320
7. Goodwin PJ Boyd NF: Body Size andABreast Cancer Prognosis: a Critical Review of the Evidence. Breast Cancer Res Treat 1990, 16(3):205-14. 10.1007/BF01806329 2085672
8. Chlebowski RT Aiello E McTiernan A: Weight Loss in Breast Cancer Patient Management. J Clin Oncol 2002, 20(4):1128-43. 10.1200/JCO.20.4.1128 11844838
9. Enger SM Greif JM Polikoff J Press M: Body Weight Correlates With Mortality in Early-Stage Breast Cancer. Arch Surg 2004, 139(9):954-8. 10.1001/archsurg.139.9.954 15381612
10. Daling JR Malone KE Doody DR Johnson LG Gralow JR Porter PL: Relation of Body Mass Index to Tumor Markers and Survival Among Young Women With Invasive Ductal Breast Carcinoma. Cancer 2001, 92(4):720-9. 10.1002/ 1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T 11550140
11. Miller KD Sledge GW Jr: Toward Checkmate: Biology and Breast Cancer Therapy for the New Millennium. Invest New Drugs 1999, 17(4):417-27. 10.1023/A:1006311227965 10759407
12. Menendez JA Vellon L Lupu R: The Antiobesity Drug Orlistat Induces Cytotoxic Effects, Suppresses Her-2/Neu (ErbB-2) Oncogene Overexpression, and Synergistically Interacts With Trastuzumab (Herceptin) in Chemoresistant Ovarian Cancer Cells. Int J Gynecol Cancer 2006, 16(1):219-21. 10.1111/j.1525-1438.2006.00297.x 16445636
13. Menendez JA Vellon L Lupu R: Antitumoral Actions of the Anti-Obesity Drug Orlistat (XenicalTM) in Breast Cancer Cells: Blockade of Cell Cycle Progression, Promotion of Apoptotic Cell Death and PEA3-Mediated Transcriptional Repression of Her2/Neu (ErbB-2) Oncogene. Ann Oncol 2005, 16(8):1253-67. 10.1093/annonc/mdi239 15870086
14. Colomer R Menendez JA: Mediterranean Diet, Olive Oil and Cancer. Clin Transl Oncol 2006, 8(1):15-21. 10.1007/s12094-006-0090-0 16632435
15. Anim JT John B Abdulsathar SSA Prasad A Saji T Akhtar N Ali V Al Saleh M: Relationship Between the Expression of Various Markers and Prognostic Factors in Breast Cancer. Acta Histochem 2005, 107(2):87-93. 10.1016/ j.acthis.2005.01.002 15950051
16. Honda H Ohi Y Umekita Y Takasaki T Kuriwaki K Ohyabu I Yoshioka T Yoshida A Taguchi S Ninomiya K Akiba S Nomura S Sagara Y Yoshida H: Obesity Affects Expression of Progesterone Receptors and Node Metastasis of Mammary Carcinomas in Postmenopausal Women Without a Family History. Pathol Int 1999, 49(3):198-202. 10.1046/j.1440-1827.1999.00846.x 10338073